# Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2)

> **NCT04140110** · NA · TERMINATED · sponsor: **The George Institute for Global Health, China** · enrollment: 816 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **OTHER:** Intensive BP lowering

## Key facts

- **NCT ID:** NCT04140110
- **Lead sponsor:** The George Institute for Global Health, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-20
- **Primary completion:** 2022-07-15
- **Final completion:** 2022-10-31
- **Target enrollment:** 816 (ACTUAL)
- **Why stopped:** Data Safety Monitoring Board recommendation based on consistent safety concerns that recruitment be discontinued and the data analysed and reported. Protocol amendment planned.
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04140110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04140110, "Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04140110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*